Sculptor Capital LP Biomarin Pharmaceutical Inc Transaction History

Sculptor Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $1.65 Million - $2.2 Million	18,799 New	18,799 $1.83 Million
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $1.76 Million - $2.39 Million	-24,670 Reduced 74.94%	8,249 $697,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $104,438 - $140,351	1,625 Added 5.19%	32,919 $2.78 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $626,415 - $791,012	9,294 Added 42.25%	31,294 $2.11 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.77 Million - $2.07 Million	22,000 New	22,000 $1.88 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.